- The FDA is getting closer to authorizing Novavax Inc.’s COVID-19 vaccine after the company said it fixed production issues that delayed its application. However, U.S. clearance for the protein-based shot is still a ways off given the FDA must review a lot of data from several countries. Regulators in other countries have authorized Novavax’s vaccine. Health experts hope that offering a protein-based vaccine will help convince those who are wary of mRNA shots to get vaccinated. (Article here)
March 7, 2022
Monday, March 7, 2022: Life Sciences
Jordana is the senior vice president of communications and executive advisor. In this role, she collaborates closely with the CEO and president to design and implement policies, practices, and communications plans to help the firm shape a future system that actualizes a sustainable culture of health nationwide. Jordana has over 17 years of health, communications, and strategic planning experience in the private and public sector. She is certified to teach group fitness through the American Council and Exercise and holds a RYT-200 yoga teacher certification.